A total of 522 patients with hypertension and/or dyslipidemia who had one or more silent cerebral infarcts , advanced carotid atherosclerosis or microalbuminuria at baseline were randomly treated with ( n = 254 ) or without pioglitazone ( n = 268 ) and observed for a medium of 672 days .